BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23469311)

  • 41. In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.
    Schmid C; Kuemmerle A; Blum J; Ghabri S; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Tete D; Mubwa N; Kisala M; Blesson S; Mordt OV
    PLoS Negl Trop Dis; 2012; 6(11):e1920. PubMed ID: 23209861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis.
    Tiberti N; Hainard A; Lejon V; Robin X; Ngoyi DM; Turck N; Matovu E; Enyaru J; Ndung'u JM; Scherl A; Dayon L; Sanchez JC
    Mol Cell Proteomics; 2010 Dec; 9(12):2783-95. PubMed ID: 20724469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The separation of trypanosomes from blood by anion exchange chromatography: From Sheila Lanham's discovery 50 years ago to a gold standard for sleeping sickness diagnosis.
    Lejon V; Büscher P; Nzoumbou-Boko R; Bossard G; Jamonneau V; Bucheton B; Truc P; Lemesre JL; Solano P; Vincendeau P
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007051. PubMed ID: 30817751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis.
    Gineau L; Courtin D; Camara M; Ilboudo H; Jamonneau V; Dias FC; Tokplonou L; Milet J; Mendonça PB; Castelli EC; Camara O; Camara M; Favier B; Rouas-Freiss N; Moreau P; Donadi EA; Bucheton B; Sabbagh A; Garcia A
    Clin Infect Dis; 2016 Nov; 63(9):1189-1197. PubMed ID: 27470243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness.
    Milord F; Loko L; Ethier L; Mpia B; Pépin J
    Trans R Soc Trop Med Hyg; 1993; 87(4):473-7. PubMed ID: 8249087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness).
    Kennedy PG
    Lancet Neurol; 2013 Feb; 12(2):186-94. PubMed ID: 23260189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Actigraphy in human African trypanosomiasis as a tool for objective clinical evaluation and monitoring: a pilot study.
    Njamnshi AK; Seke Etet PF; Perrig S; Acho A; Funsah JY; Mumba D; Muyembe JJ; Kristensson K; Bentivoglio M
    PLoS Negl Trop Dis; 2012; 6(2):e1525. PubMed ID: 22348168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for the occurrence of Trypanosoma brucei rhodesiense sleeping sickness outside the traditional focus in south-eastern Uganda.
    Enyaru JC; Odiit M; Winyi-Kaboyo R; Sebikali CG; Matovu E; Okitoi D; Olaho-Mukani W
    Ann Trop Med Parasitol; 1999 Dec; 93(8):817-22. PubMed ID: 10715675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Priorities for the elimination of sleeping sickness.
    Welburn SC; Maudlin I
    Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo.
    Balasegaram M; Harris S; Checchi F; Hamel C; Karunakara U
    Bull World Health Organ; 2006 Oct; 84(10):777-82. PubMed ID: 17128357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using detergent-enhanced LAMP for African trypanosome detection in human cerebrospinal fluid and implications for disease staging.
    Grab DJ; Nikolskaia OV; Courtioux B; Thekisoe OMM; Magez S; Bogorad M; Dumler JS; Bisser S
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007631. PubMed ID: 31425540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: A retrospective analysis from the Guinean national Human African Trypanosomiasis control program.
    Camara M; Ouattara E; Duvignaud A; Migliani R; Camara O; Leno M; Solano P; Bucheton B; Camara M; Malvy D
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006060. PubMed ID: 29131822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacokinetics of eflornithine (alpha-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness.
    Na-Bangchang K; Doua F; Konsil J; Hanpitakpong W; Kamanikom B; Kuzoe F
    Eur J Clin Pharmacol; 2004 Jun; 60(4):269-78. PubMed ID: 15141331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diagnosis of sleeping sickness stage: towards a new approach].
    Lejon V; Büscher P
    Bull Soc Pathol Exot; 2002 Dec; 95(5):338-40. PubMed ID: 12696371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Human African trypanosomiasis and normality of the cerebrospinal fluid].
    Pepin J; Milord F; Guern C
    Med Trop (Mars); 1989; 49(1):29-31. PubMed ID: 2725242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biological data and clinical symptoms as predictors of astrogliosis and neurodegeneration in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.
    Lejon V; Legros D; Rosengren L; Gastellu Etchegorry M; Büscher P
    Am J Trop Med Hyg; 2001 Dec; 65(6):931-5. PubMed ID: 11792001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebrospinal fluid B lymphocyte identification for diagnosis and follow-up in human African trypanosomiasis in the field.
    Bouteille B; Mpandzou G; Cespuglio R; Ngampo S; Peeling RW; Vincendeau P; Buguet A
    Trop Med Int Health; 2010 Apr; 15(4):454-61. PubMed ID: 19807900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients.
    Lejon V; Rosengren LE; Buscher P; Karlsson JE; Sema HN
    Am J Trop Med Hyg; 1999 Jan; 60(1):94-8. PubMed ID: 9988330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sleeping sickness from early diagnosis to post-therapy follow-up].
    Wery M
    Bull Mem Acad R Med Belg; 1986; 141(2):203-12. PubMed ID: 3533186
    [No Abstract]   [Full Text] [Related]  

  • 60. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings.
    Wengert O; Kopp M; Siebert E; Stenzel W; Hegasy G; Suttorp N; Stich A; Zoller T
    Parasitol Int; 2014 Jun; 63(3):557-60. PubMed ID: 24613272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.